B

Bruker

Manufactures analytical instruments for NMR diagnostics

Technical Sales & Business Development Manager

Full-TimeDeadline 10/7/27
No salary listed
Senior
Bachelor's
Perth, UK
HybridHybrid home working is available; international travel is essential.
Sales & Account ManagementAccount Management, Business Development & Partnerships

About the job

Requirements
  • A degree in Engineering, Materials Science, Physics, or a related technical discipline is required.
  • At least five years of industrial experience in a technical, commercial, or business development role is required.
  • A full UK driving licence is required.
  • The candidate must be able to travel internationally without restriction.
  • Proven experience in technical sales, business development, or account management is required.
  • Experience selling engineered, industrial, or technical products into international markets is required.
  • The candidate must be able to interpret technical requirements and translate them into commercial opportunities.
  • Experience managing customer relationships and delivering revenue growth is required.
  • Understanding of commercial compliance requirements, export controls, or international trade practices is required.
  • Excellent written and verbal communication skills are required.
Responsibilities
  • Manage and develop existing customer accounts with annual sales exceeding £3 million.
  • Identify, qualify, and pursue new business opportunities across international markets, including North America, South America, Europe, and Asia.
  • Build and maintain relationships with customers, distributors, and strategic partners.
  • Develop and implement sales strategies to increase market penetration and revenue growth.
  • Promote Cuponal products through direct customer engagement, technical presentations, conferences, and industry exhibitions.
  • Respond to customer enquiries and convert qualified opportunities into profitable business.
  • Prepare marketing materials and campaigns in collaboration with business development teams across the group.
  • Develop a thorough understanding of Cuponal products, capabilities, and competitive advantages.
  • Identify new applications, industries, and niche opportunities where Cuponal can deliver customer value.
  • Support customers in understanding product specifications, standards, and performance characteristics.
  • Collaborate with internal engineering and production teams to deliver customer-focused solutions.
  • Contribute to the development of innovative products and routes to market.
  • Support and maintain corporate compliance requirements throughout the sales process.
  • Conduct customer due diligence and third-party compliance reviews in accordance with Bruker policies.
  • Ensure commercial activities comply with applicable export controls, international trade regulations, and corporate governance requirements.
  • Monitor industry standards and regulatory developments affecting international sales.
  • Contribute to annual business planning, sales forecasting, and budget development.
  • Provide market intelligence, competitor analysis, and customer insights to support business growth initiatives.
  • Work with local management, finance, and Bruker's global business development teams to implement growth strategies.
Desired Qualifications
  • Knowledge of electrical conductors, power distribution systems, bus bars, or related electrical infrastructure products.
  • Experience working with distributors and channel partners.
  • Familiarity with European and international regulatory frameworks affecting industrial products.
  • Experience within metals, advanced materials, or manufacturing environments.

About the company

Bruker makes analytical and diagnostic instruments used by researchers and industries. Its products help analyze materials and biological samples to reveal chemical structure, composition, and properties, with notable roots in nuclear magnetic resonance (NMR) technology and a broad portfolio beyond that field. The company works by designing and selling instruments such as analytical tools that collect data from samples (for example, signals from nuclei in NMR or other spectroscopic methods) and provide insights to researchers. Bruker differentiates itself through a long history of developing advanced technologies, a focus on innovation in scientific instrumentation, and a global product range serving life sciences, materials science, and environmental analysis, supported by steady investment in research and development. Its goal is to equip researchers and industries with reliable tools to push the boundaries of what is possible in science and discovery.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Billerica, Massachusetts

Founded

1960

Get referred to Bruker

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • September 28, 2026 timsUltra AIP and timsOmni launches deepen proteomics and oligonucleotide workflows.
  • August 10, 2026 MIMETAS deal expands Bruker into human-relevant drug discovery models.
  • UC Berkeley ordered over $6 million of Bruker NMR systems, delivering 2027 revenue.

What critics are saying

  • Bruker’s first-half 2026 organic revenue declined 0.8%, exposing fragile demand recovery.
  • Academic spending stayed soft in 2026, while tariffs and currency pressured results.
  • If MIMETAS and fusion remain niche, Bruker’s acquisition-heavy strategy destroys capital returns.

What makes Bruker unique

  • Bruker owns timsTOF proteomics, NMR, microscopy, and microphysiological systems under one platform.
  • Bruker’s August 31 XFlash 7200 FIRE raises SEM-EDS throughput beyond conventional detector designs.
  • Bruker’s BEST superconductors supply ITER, Wendelstein 7-X, CERN, and fusion demonstrators.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Employee Stock Purchase Plan
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • Disability Insurance
  • Life Insurance
  • Dental Insurance
  • Flexible Work Hours
  • Employee Discounts

Growth & Insights and Company News

Headcount

6 month growth

10%

1 year growth

13%

2 year growth

13%
Business Wire
Oct 14th, 2026
Bruker Completes Acquisition of PhenomeX

Bruker Corporation (Nasdaq: BRKR) today announced that it has completed the acquisition of PhenomeX, a leading provider of single-cell biology research tools...

Financial Times
Sep 28th, 2026
Bruker advances functional proteomics with novel timsUltra AIP and timsOmni workflows for drug discovery & development and disease biology research.

Bruker advances functional proteomics with novel timsUltra AIP and timsOmni workflows for drug discovery & development and disease biology research. Sep 28 2026 12:00 BST * MultiDIA-PASEF significantly increases protein sequence coverage on timsUltra AIP * ProteoScape connects PASEF discovery with rapid prm-PASEF target validation * Spectronaut(R) AI transfer learning accelerates adaptation to new MS capabilities * Guided PASEF EXciD enables high-throughput glycopeptide characterization * Integrated HDX-MS workflows advance protein conformation and interaction studies * timsOmni(TM) enables RNA and DNA top-down structural and native RNA analysis SINGAPORE-(BUSINESS WIRE)-Sep. 28, 2026- At the Human Proteome Organization World Congress 2026, Bruker Corporation (Nasdaq: BRKR) today announced unique new timsUltra AIP and timsOmni workflows for deeper protein-sequence coverage, targeted validation, mobility-resolved glycopeptide characterization, structural proteomics, and oligonucleotide analysis. Multi-enzyme dia-PASEF provides additional peptide information for investigations of isoforms and proteoforms, while ProteoScape workflows connect PASEF discovery with prm-PASEF target validation on the same timsTOF platform. Novel timsOmni and integrated HDX-MS workflows extend structural analysis to glycopeptides, proteins, and nucleic acids.

MarketScreener
Sep 21st, 2026
Bruker Corporation receives order from University of California, Berkeley for high-field nmr systems for major upgrade of Magnetic Resonance research infrastructure.

Bruker Corporation receives order from University of California, Berkeley for high-field nmr systems for major upgrade of Magnetic Resonance research infrastructure. Published on 09/21/2026 at 09:36 am EDT S&P Capital IQ Bruker Corporation announced a multi-system order from University of California, Berkeley for high-field Nuclear Magnetic Resonance (NMR) instrumentation at the Pines Magnetic Resonance Center. The investment will enhance access to next-generation NMR technologies, including 800 MHz?class instrumentation. The investment is centered on a Bruker AV NEO-X 800 MHz spectrometer equipped with a cryogenically cooled MAS CryoProbe, complemented by several additional NMR systems and upgrades supporting solid-state, solution-state and Dynamic Nuclear Polarization (DNP) research. The UC Berkeley NMR order exceeds USD 6 million and is expected to be delivered in 2027. (C) S&P Capital IQ - 2026

U.S. Securities and Exchange Commission
Sep 19th, 2026
10-K

Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities

U.S. Securities and Exchange Commission
Sep 18th, 2026
10-Q

Unaudited Condensed Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023